Decisional regret and quality of life after participating in medical decision-making for early-stage prostate cancer

被引:77
|
作者
Davison, BJ
Goldenberg, SL
机构
[1] Vancouver Gen Hosp, Prostate Ctr, Vancouver, BC, Canada
[2] Univ British Columbia, Fac Med, Vancouver, BC V5Z 1M9, Canada
关键词
decision-making; decisional regret; quality of life; prostate cancer;
D O I
10.1046/j.1464-410X.2003.04005.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
To determine the effect of men's reported levels of involvement in medical decision-making and quality of life (QoL) on their levels of decisional regret after definitive treatment. Men referred to a hospital-based resource centre completed QoL and decisional-regret measures after definitive treatment for localized prostate cancer. Data from these questionnaires were linked with a previous study conducted to determine if providing individualized information to men newly diagnosed with prostate cancer would lower their levels of psychological distress and enable them to become more active participants in treatment decision-making. The preferred role in medical decision-making and QoL had previously been measured at the time of diagnosis and the assumed role at 4 months after the definitive treatment decision. This postal survey was conducted approximate to 18 months after diagnosis. Of 74 men, 67 (91%) responded; the mean (sd) time since definitive treatment was 10.3 (4.7) months and the mean age of the men 62.5 (6.9) years. Radical prostatectomy was the most frequent treatment (72%). Most (94%) patients participated in medical decision-making either actively or collaboratively and did not regret their treatment choice. The type of definitive treatment received had no effect on decisional regret; patients' QoL scores were similar to the levels before treatment. Levels of sexual function were significantly lower after definitive treatment, but urinary incontinence was not significantly affected. Men who had neoadjuvant hormone therapy reported having significantly more treatment-related symptoms. There is no evidence that providing information to facilitate participation in medical decision-making causes decisional regret or psychological distress within the first year after definitive treatment. A longitudinal follow-up of these patients is required to adequately assess the long-term effects of treatment on QoL and decisional regret.
引用
收藏
页码:14 / 17
页数:4
相关论文
共 50 条
  • [1] Treatment decision-making in early-stage prostate cancer
    Denberg, TD
    Melhado, TV
    Kim, JF
    Steiner, JF
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2005, 20 : 194 - 194
  • [2] Long-term analysis of treatment decision regret: Importance of the decision-making process and postoperative HRQOL after treatment for early-stage prostate cancer
    Osawa, T.
    Sato, M.
    Nishioka, K.
    Miyazaki, T.
    Takahashi, S.
    Mori, T.
    Hashimoto, T.
    Miyata, H.
    Matsumoto, R.
    Abe, T.
    Ohashi, K.
    Murai, S.
    Ito, Y. M.
    Shinohara, N.
    [J]. EUROPEAN UROLOGY, 2024, 85 : S74 - S75
  • [3] MRD and Decision-Making in Early-Stage Colorectal Cancer
    Lieu, Christopher
    Ahn, Daniel
    [J]. ONCOLOGY-NEW YORK, 2021, 35 (08): : 501 - 503
  • [4] Racial differences in treatment decision-making patterns and decisional regret in patients with localized prostate cancer.
    Kim, Daniel J.
    Hurwitz, Lauren
    Cullen, Jennifer
    Hudak, Jane
    Colston, Maryellen
    Travis, Judith
    Elsamanoudi, Sally
    Rosner, Inger L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [5] Quality of Life–Focused Decision-Making for Prostate Cancer
    Jeffrey Shevach
    Adam Weiner
    Alicia K. Morgans
    [J]. Current Urology Reports, 2019, 20
  • [6] Patients' preferences for communicating a prostate cancer diagnosis and participating in medical decision-making
    Davison, BJ
    Parker, PA
    Goldenberg, SL
    [J]. BJU INTERNATIONAL, 2004, 93 (01) : 47 - 51
  • [7] Treatment decision regret in men with early-stage prostate cancer: Findings from the UK-wide life after prostate cancer diagnosis (LAPCD) study
    Wilding, Sarah
    Watson, Eila
    Downing, Amy
    Wright, Penny
    Wagland, Richard
    Selby, Peter J.
    Donnelly, David
    Gavin, Anna
    Glaser, Adam
    [J]. PSYCHO-ONCOLOGY, 2018, 27 : 171 - 171
  • [8] THE INFLUENCE OF QUALITY OF RISK COMMUNICATION AND PATIENT CONFIDENCE ON DECISIONAL REGRET AND WORRY IN MEN UNDERGOING TREATMENT FOR EARLY-STAGE PROSTATE CANCER (PCA)
    Fagerlin, Angela
    Wallner, Lauren P.
    Dunn, Rodney L.
    Holmes-Rovner, Margaret
    Rovner, David
    Wei, John T.
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2010, 39 : 132 - 132
  • [9] Quality of Life-Focused Decision-Making for Prostate Cancer
    Shevach, Jeffrey
    Weiner, Adam
    Morgans, Alicia K.
    [J]. CURRENT UROLOGY REPORTS, 2019, 20 (10)
  • [10] The information needed by Canadian early-stage prostate cancer patients for decision-making: Stable over a decade
    Feldrnan-Stewart, Deb
    Brennenstuhl, Sarah
    Brundage, Michael D.
    [J]. PATIENT EDUCATION AND COUNSELING, 2008, 73 (03) : 437 - 442